Mersana Therapeutics, Inc. (MRSN) Net Income by Year
Mersana Therapeutics, Inc. reported a net loss of $69.2M in fiscal year 2024. This represents an increase of 59.7% from the prior fiscal year. Over the trailing 12 months, Q4 FY2024 through Q3 FY2025, the same line adds up to a $70.1M net loss. The table below carries 10 fiscal years, from 2015 to 2024, and the quarters Mersana Therapeutics, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
MRSN Net Income by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
TTM is the trailing twelve months, Q4 FY2024 through Q3 FY2025, summed from the four most recent quarterly filings.
MRSN Net Income by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What net income means
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.
More Mersana Therapeutics, Inc. financials
Frequently Asked Questions
What was Mersana Therapeutics, Inc.'s net income in fiscal year 2024?
Mersana Therapeutics, Inc. reported a net loss of $69.2M in fiscal year 2024.
How fast is Mersana Therapeutics, Inc.'s net income growing?
Mersana Therapeutics, Inc. (MRSN) net income rose by 59.7% year over year, from -$171.7M to -$69.2M in fiscal year 2024.
What is Mersana Therapeutics, Inc.'s net income over the last twelve months?
Mersana Therapeutics, Inc. (MRSN) reported a $70.1M net loss over the trailing 12 months, Q4 FY2024 through Q3 FY2025, summed from the four most recent quarterly filings.
How has Mersana Therapeutics, Inc.'s net income changed over the years?
Across the 10 fiscal years this page covers, Mersana Therapeutics, Inc. (MRSN) net income went from -$16.4M in fiscal year 2015 to -$69.2M in fiscal year 2024.
What was Mersana Therapeutics, Inc.'s net income in the most recent quarter?
Mersana Therapeutics, Inc. (MRSN) reported -$7.5M in net income in Q3 2025. This represents an increase of 34.4% from the same quarter a year earlier.
What does net income mean on a financial statement?
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Mersana Therapeutics, Inc. (MRSN) reported on that line in every period on record.